75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
995457 - Disclosure - Overview
link:presentationLink
link:calculationLink
link:definitionLink
995467 - Disclosure - Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995477 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995487 - Disclosure - Fair Value of Financial Instruments
link:presentationLink
link:calculationLink
link:definitionLink
995497 - Disclosure - Balance Sheet Components
link:presentationLink
link:calculationLink
link:definitionLink
995507 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
995517 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995527 - Disclosure - Long-term Debt
link:presentationLink
link:calculationLink
link:definitionLink
995537 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995547 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
995557 - Disclosure - Net Income (Loss) per Share
link:presentationLink
link:calculationLink
link:definitionLink
995567 - Disclosure - Defined Contribution Plan
link:presentationLink
link:calculationLink
link:definitionLink
995577 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995587 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995597 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995607 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995617 - Disclosure - Fair Value of Financial Instruments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995627 - Disclosure - Balance Sheet Components (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995637 - Disclosure - Warrants (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995647 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995657 - Disclosure - Long-term Debt (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995667 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995677 - Disclosure - Income Taxes (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995687 - Disclosure - Net Income (Loss) per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995697 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995707 - Disclosure - Liquidity - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995717 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995727 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Product Revenue Allowance and Reserve Categories (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995737 - Disclosure - Fair Value of Financial Instruments - Schedule of Marketable Securities Classified as Available-for-sale Securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995747 - Disclosure - Fair Value of Financial Instruments - Summary of Financial Instruments Measured at Fair Value on Recurring Basis (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995757 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995767 - Disclosure - Fair Value of Financial Instruments - Summary of Changes in Fair Value of Level 3 Financial Instruments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995777 - Disclosure - Balance Sheet Components - Schedule of Inventory (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995787 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995797 - Disclosure - Balance Sheet Components - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995807 - Disclosure - Balance Sheet Components - Intangible Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995817 - Disclosure - Balance Sheet Components - Future Amortization Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995827 - Disclosure - Balance Sheet Components - Schedule of Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995837 - Disclosure - Warrants - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995847 - Disclosure - Warrants - Fair Value of Convertible Preferred Stock Warrant Liability (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995857 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995867 - Disclosure - Commitments and Contingencies - Schedule of Components of Lease Expense (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995877 - Disclosure - Commitments and Contingencies - Schedule of Components of Lease Expense (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
995887 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Leases (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995897 - Disclosure - Commitments and Contingencies - Reconciliation of Undiscounted Future Minimum Lease Payments Remaining under Operating Lease (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995907 - Disclosure - Commitments and Contingencies - Reconciliation of Undiscounted Future Minimum Lease Payments Remaining under Operating Lease (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
995917 - Disclosure - Long-term Debt - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995927 - Disclosure - Long-term Debt - Schedule of outstanding long-term debt (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995937 - Disclosure - Long-term Debt - Schedule Of Interest Expense Related to the Long-term Debt (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995947 - Disclosure - Stockholders' Equity - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995957 - Disclosure - Stockholders' Equity - Summary of Outstanding Common Stock Warrants (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995967 - Disclosure - Stockholders' Equity - Summary of Stock Based Compensation Expense (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995977 - Disclosure - Stockholders' Equity - Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995987 - Disclosure - Stockholders' Equity - Summary of Stock Option and Restricted Stock Unit Transactions (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995997 - Disclosure - Stockholders' Equity - Summary of Restricted Stock Unit Transactions (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996007 - Disclosure - Income Taxes - Schedule of Income (Loss) before Provision for Income Taxes (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996017 - Disclosure - Income Taxes - Summary of Income Taxes Paid, Net of Refunds Received (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996027 - Disclosure - Income Taxes - Income Tax Provision (Benefit) Computed by Applying Statutory Income Tax Rate to Pretax Income (Loss) (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996037 - Disclosure - Income Taxes - Significant Components of Company's Deferred Tax Assets and Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996047 - Disclosure - Income Taxes - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996057 - Disclosure - Income Taxes - Summary of Change in the Valuation Allowance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996067 - Disclosure - Income Taxes - Summary of Gross Unrecognized Tax Benefits (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996077 - Disclosure - Net Income (Loss) per Share - Schedule of Weighted-Average Common Shares Outstanding used to Calculate Basic and Diluted Net Income (Loss) per Common Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996087 - Disclosure - Net Income (Loss) per Share - Schedule of Weighted-Average Common Shares Outstanding used to Calculate Basic and Diluted Net Income (Loss) per Common Share (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
996097 - Disclosure - Net Income (Loss) per Share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Net Income (Loss) per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996107 - Disclosure - Defined Contribution Plan - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
996117 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996127 - Disclosure - Segment Reporting - Schedule of Cash Operating Expenses Reconciled to Net Income (Loss) on Consolidated Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996137 - Disclosure - Subsequent Events - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Restricted stock units vested (in dollars per share)
Income (Loss) from Continuing Operations before Income Taxes, Foreign
Foreign
Concentration of Major Customers and Off-Balance Sheet Risk
Major Customers, Policy [Policy Text Block]
Debt Instrument, Additional Borrowing Amount
Debt instrument, additional borrowing amount.
Debt instrument additional borrowing amount
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Balance at end of period
Balance at the beginning of period
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
Summary of Financial Instruments Measured at Fair Value on Recurring Basis
Long-Term Debt, Excluding Current Maturities
Long-term debt, net
Total long-term debt, net
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
Effect of dilutive securities warrants
Schedule of Long-Term Debt Instruments [Table Text Block]
Schedule Of Outstanding Long-term Debt
Summary of Product Revenue Allowance and Reserve Categories [Table Text Block]
Summary of product revenue allowance and reserve categories.
Summary of Product Revenue Allowance and Reserve Categories
Plan Name [Axis]
Plan Name
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Non-cancelable other commitments
Other Commitment
Other Commitment, Total
Proceeds from warrant exercise
Proceeds from Warrant Exercises
Fair Value, Inputs, Level 2 [Member]
Level 2 [Member]
Deferred Tax Assets, Net of Valuation Allowance
Total deferred tax assets
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Massachusetts
MASSACHUSETTS
Deferred Tax Assets, Capital Loss Carryforwards
Capital loss carryforward
Product and Service [Axis]
Fair Value by Liability Class [Domain]
Fair Value by Liability Class
Long-term Accrued Interest Payable Noncurrent
Long-term accrued interest payable noncurrent.
Long-term accrued interest payable
Document Fiscal Period Focus
Document Fiscal Period Focus
Debt Instrument, Interest Rate, Stated Percentage
Debt Instrument interest rate stated percentage
Accounting Standards Update 2023-09 [Member]
ASU No. 2023-09 [Member]
Entity Shell Company
Entity Shell Company
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Operating Lease Right-Of-Use Asset Increase
Operating lease right-of-use asset increase.
Increase in right of use assets
Segment Reporting, Policy [Policy Text Block]
Segments
Cash and Cash Equivalent
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Lessee, Operating Lease, Description
Operating lease, description
Asset Class [Domain]
NEW JERSEY
New Jersey
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Increase related to current year tax positions
Internal Revenue Service (IRS) [Member]
Internal Revenue Service (IRS) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value per option granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Percentage of fair market value
Revenue Recognition
Revenue from Contract with Customer [Policy Text Block]
Entity Filer Category
Entity Filer Category
Commitments and contingencies.
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Debt Instrument [Line Items]
Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
Effective Income Tax Rate Reconciliation, Tax Contingency, Percent, Total
Worldwide changes in UTB
Amortization
Amortization
Amortization, Total
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset
Debt Instrument, Frequency of Periodic Payment
Debt instrument frequency of periodic payment
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Increase (decrease) in valuation allowance
Debt Instrument, Date of First Required Payment
Debt instrument date of first required payment
Cash and Cash Equivalents, Fair Value Disclosure
Total cash equivalents
Deferred Tax Assets, Valuation Allowance
Valuation allowance
Ending balance
Beginning balance
Debt instrument maturity extension period
Debt Instrument Maturity Extension Period
Debt instrument maturity extension period.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Tax at statutory rate on income before income taxes
Shares Issued, Price Per Share
Price per unit
Section 382 limitation
Income Tax Reconciliation Section 382 Limitation
Income tax reconciliation section 382 limitation.
Section 382 limitation
Subsequent Event [Line Items]
2018 PIPE warrant liability.
Two Thousand Eighteen P I P E Warrant Liability [Member]
2018 PIPE Warrant Liability [Member]
2018 PIPE Warrants [Member]
Documents Incorporated by Reference [Text Block]
Documents Incorporated by Reference
Effective Income Tax Rate Reconciliation, Percent
Provision for income taxes
Stock Options [Member]
Convertible Debt Securities [Member]
Warrants Issued to 2010/2012 Convertible Note Holders to Purchase Common Stock [Member]
Income Tax Jurisdiction [Axis]
Income Tax Authority
Proceeds from offering after deducting underwriting discount and other estimated offering expenses.
Proceeds From Offering After Deducting Underwriting Discount And Other Estimated Offering Expenses
Proceeds from offering after deducting underwriting discount and other estimated offering expenses
Geographical [Domain]
Geographical
Inventory, Finished Goods, Gross
Finished goods
Schedule of Inventory, Current [Table Text Block]
Schedule of Inventory
Share based compensation arrangement by share based payment award options non vested aggregate intrinsic value.
Share Based Compensation Arrangement By Share Based Payment Award Options Non Vested Aggregate Intrinsic Value
Aggregate Intrinsic Value
Debt Issuance Costs, Net
Debt Issuance Costs, Net, Total
Loan issuance costs
Deferred Tax Assets, Property, Plant and Equipment
Fixed assets
Aggregrate Offering Price
Aggregrate Offering Price
Aggregrate offering price.
Aggregrate Offering Price
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Percentage of Aggregate Gross Proceeds to Pay Commission
Percentage of aggregate gross proceeds to pay commission.
Percentage of aggregate gross proceeds to pay commission
Measurement Input, Risk Free Interest Rate [Member]
Risk-free Rate [Member]
Finite-Lived Intangible Asset, Useful Life
Estimated useful life
Balance Sheet Components Disclosure [Abstract]
Balance sheet components disclosure.
Debt Instrument, Maturity Date, Description
Debt instrument maturity date description
Vesting [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of options granted
Options granted
Schedule of Weighted-Average Common Shares Outstanding used to Calculate Basic and Diluted Net Income (Loss) per Common Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Provisions
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Summary of Income Taxes Paid, Net of Refunds Received [Table Text Block]
Summary of Income Taxes Paid, Net of Refunds Received.
Summary of Income Taxes Paid, Net of Refunds Received
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Net income (loss) per share - basic
Unrecognized Tax Benefits Offset By Valuation Allowance
Unrecognized Tax Benefits Offset By Valuation Allowance
Unrecognized tax benefit offset by change in valuation allowance
Retirement Benefits [Text Block]
Defined Contribution Plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Ending balance
Beginning balance
Contingent upon FDA Approval of DCCR for Treatment of PWS Tranche Two [Member]
Contingent upon FDA approval of DCCR for treatment of PWS tranche two.
Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]
Schedule of Marketable Securities Classified as Available-for-sale Securities
Debt, Policy [Policy Text Block]
Debt
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of Changes in Fair Value of Level 3 Financial Instruments
U.S. Federal
Income Tax Paid, Federal, after Refund Received
Income Tax Paid, Federal, after Refund Received, Total
Domestic Tax Jurisdiction [Member]
U.S. Federal Jurisdiction [Member]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
Credits/payments
Credits/payments
Interest Expense, Debt, Excluding Amortization
Interest expense based on contractual loan rate
Effective Income Tax Rate Reconciliation [Table]
Increase related to prior year tax positions
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions
Accounting Standards Update [Axis]
Entity Small Business
Entity Small Business
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit), Total
Deferred tax assets:
Deferred Tax Assets, Net of Valuation Allowance [Abstract]
Stock based compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Amount
Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Amount, Total
Cross-border tax laws
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Increase in lease liability
Increase In Operating Lease Liability
Increase in operating lease liability.
Proceeds from Issuance Initial Public Offering
Net proceeds from issuance of public offering
Milestone Achieved on or After December Seventeen Two thousand Twenty Five [Member]
Milestone Achieved on or After December Seventeen Two thousand Twenty Five [Member]
Intrinsic value of stock options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Contingent consideration remeasurement, Percent
Effective income tax rate reconciliation, nondeductible expense, contingent consideration remeasurement, percent.
Contingent consideration remeasurement
Warrants and Rights Outstanding, Measurement Input
Measurement input
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Sharebased Compensation Arrangementby Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value Roll Forward
Weighted-Average Exercise Price per Share
Loan available in additional tranches
Loan Available In Additional Tranches
Loan Available In Additional Tranches
Banking [Member]
Silicon Valley Bank [Member]
Inventory Valuation Reserves
Less: Reserve for excess and obsolete inventory
Debt Instrument, Payment Terms
Debt instrument payment terms
Amendment Flag
Amendment Flag
Product and Service [Domain]
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Tax at statutory rate on income before income taxes
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Number of common stock purchased upon issuance of warrants
Number of common stock purchased upon issuance of warrants
Accrued Research and development Costs
Accrued research and development costs.
Accrued research and development costs
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Accounts Receivable, net
Accounts Receivable [Policy Text Block]
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Net cash used in operating activities
Net cash provided by (used in) operating activities
Asset purchase.
Asset Purchase [Axis]
Asset Purchase
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock [Member]
Common Stock [Member]
Unrecognized assets and liabilities related to uncertain tax positions.
Unrecognized Assets And Liabilities Related To Uncertain Tax Positions
Unrecognized assets and liabilities related to uncertain tax positions
Operating loss carryforwards carried forward indefinitely.
Operating Loss Carryforwards Carried Forward Indefinitely
Operating loss carryforwards, carried forward indefinitely
Tax Credit Carryforward, Amount
Tax credit carryforwards
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Options granted (in dollars per share)
Lessee, Operating Lease, Liability, to be Paid, Year Three
2028
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
May 2023 Tranche B Warrants [Member]
May Two Thousand Twenty Three Tranche B Warrants [Member]
May two thousand twenty three tranche b warrants.
Share-Based Payment Arrangement, Amount Capitalized
Stock based compensation capitalized into inventory
Warrants expire term prior to anniversary date of issuance
Warrants Expire Term Prior To Anniversary Date Of Issuance
Warrants expire term prior to anniversary date of issuance
Entity Address, Address Line One
Entity Address, Address Line One
Deferred Tax Liabilities, Gross
Deferred Tax Liabilities, Gross, Total
Total deferred tax liabilities
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Schedule of Fair Value of Award Granted Using Black-Scholes Option Pricing Model
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Earnings Per Share [Abstract]
Income Tax, Policy [Policy Text Block]
Income Taxes
Share Based Compensation Arrangement By Share Based Payment Recognized As Stock Based Compensation Expense
Share based compensation arrangement by share based payment recognized as stock based compensation expense.
Granted fair value shares recognized as stock-based compensation expense
Number of shares issued upon full exercise of underwriters options to purchase additional shares.
Number Of Shares Issued Upon Full Exercise Of Underwriters Options To Purchase Additional Shares
Shares issued upon exercise of underwriters options
Deferred Tax Assets, Gross
Gross deferred tax assets
Effective Income Tax Rate Reconciliation, State and Local Jurisdiction, Contribution Greater than 50 Percent, Tax Effect [Extensible Enumeration]
Class of Warrant or Right [Axis]
Class of Warrant or Right
Document Type
Document Type
Document Type
Income Taxes Paid, Net
Total income taxes paid
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Options exercisable at end of period
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Aggregate Intrinsic Value
Share based compensation arrangement by share based payment award options exercisable aggregate intrinsic value.
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
Patents and Merger Costs [Member]
Patents And Merger Costs [Member]
Patents and Merger Costs [Member]
Subsequent Event Type [Domain]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities excluded from computation of diluted net income (loss) per share
Class Of Warrant Or Right Exercise Price Description
Class of Warrant or Right, Exercise Price Description
Warrant issuance description
Accounting Standards Update [Domain]
Share-Based Payment Arrangement, Tranche One [Member]
Tranche A [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Options outstanding at end of period
Debt Securities, Available-for-Sale, Amortized Cost
Amortized Cost
Debt Securities, Available-for-Sale
Debt Securities, Available-for-Sale, Total
Credit losses related to available-for-sale debt securities
Estimated Fair Value
Percentage Of Probability Of Achieving Remaining Milestone
Percentage of probability of achieving remaining milestone.
Percentage of probability of achieving remaining milestone
Per share exercise price for Pre-funded warrant.
Per Share Exercise Price For Pre Funded Warrant
Per share exercise price for pre-funded warrant
Per share exercise price for pre-funded warrant
Document Financial Statement Error Correction [Flag]
Exercise of stock options (shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Options exercised
Change Charged to Income Tax Expense
Change charged to income tax expense.
Debt Disclosure [Abstract]
Marketable Securities, Total
Marketable securities
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Current Fiscal Year End Date
Current Fiscal Year End Date
Schedule of Long-Term Debt Instruments [Table]
Effective Income Tax Rate Reconciliation Orphan Drug Credit
Effective income tax rate reconciliation orphan drug credit.
Orphan Drug Credit
Rule 10b51 Arr Modified Flag
Rule 10b51 Arr Modified Flag.
Cash paid for amounts included in measurement of lease liabilities.
Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]
Cash paid for amounts included in the measurement of lease liabilities:
CALIFORNIA
Redwood City, California [Member]
California
Entity Address, State or Province
Entity Address, State or Province
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Ending balance
Beginning balance
Operating loss carryforward unavailable for future utilization
Operating Loss Carryforwards Unavailable For Future Utilization
Operating loss carryforwards unavailable for future utilization.
2028 and thereafter
Finite Lived Intangible Assets Amortization Expense Year Four And Thereafter
Finite lived intangible assets amortization expense year four and thereafter.
Two thousand twenty inducement equity incentive plan.
Two Thousand Twenty Inducement Equity Incentive Plan [Member]
2020 Inducement Equity Incentive Plan [Member]
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Unrealized Gains
Research and Development Expense, Policy [Policy Text Block]
Research and Development
Common Stock, Capital Shares Reserved for Future Issuance
Number of shares reserved for issuance
Effect of dilutive securities share based payment
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Class of Warrant or Right [Domain]
Class of Warrant or Right
Geographical [Axis]
Geographical
Ownership interest, percentage of voting rights of stock.
Ownership Interest Percentageof Voting Rightsof Stock
Ownership interest of voting rights of all classes of stock (percent)
Inventory, Raw Materials, Gross
Raw materials
Controlled equity offering sales agreement.
Controlled Equity Offering Sales Agreement [Member]
Controlled Equity Offering Sales Agreement [Member]
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount
State income taxes, net of federal effect
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Stock Based Compensation Expense
Other nontaxable or nondeductible items
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Significant Components of Company's Deferred Tax Assets and Liabilities
Equity Option [Member]
Options to Purchase Common Stock [Member]
Performance Shares [Member]
Performance-Based Options [Member]
Subsequent Event [Member]
Marketable Securities, Policy [Policy Text Block]
Marketable Securities
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total
Unamortized debt issuance costs
Unamortized debt issuance costs
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]
Measurement Input, Expected Term [Member]
Contractual Term [Member]
Debt Securities, Available-for-Sale, Current
Total marketable securities
Antidilutive Securities [Axis]
Antidilutive Securities
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage
Vesting percentage
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies [Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Fair value of restricted stock units vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Options vested and expected to vest at end of period
Income Tax Paid, Foreign, after Refund Received
Total Foreign
Total Foreign
Interest Expense, Debt
Interest expense
Total interest expense
State and Local Jurisdiction [Member]
State Tax Jurisdiction [Member]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name
Lessee, Operating Lease, Extension Expiration, Month and Year
Lessee, operating lease, extension expiration, month and year.
Operating lease, extension expiration
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill
Net intangible assets acquired
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total
Debt Instrument, Maturity Date
Debt instrument maturity date
Minimum [Member]
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Restricted stock units granted (in dollars per share)
Weighted average grant-date fair value of all restricted stock units granted
Patents And Trademark [Member]
Patents And Trademark [Member]
Patents And Trademark [Member]
Fair Value, Inputs, Level 3 [Member]
Level 3 [Member]
Liabilities, Fair Value Disclosure [Abstract]
Liabilities
Underwritter Discount and Other Offering Expenses
Underwritter discount and other offering expenses.
Underwriter discount and other offering expenses
Segment Reporting [Abstract]
Summary of Financial Instruments Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Offering costs
Stock Issued Issuance Costs
Stock issued issuance costs.
Schedule of Other Current Liabilities
Other Current Liabilities [Table Text Block]
Operating Loss Carryforwards
Operating loss carryforwards
Lessee, Leases [Policy Text Block]
Leases
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
2014 equity incentive plan.
Two Thousand And Fourteen Equity Incentive Plan [Member]
2014 Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Ending balance (in dollars per share)
Beginning balance (in dollars per share)
Warrants expiration date
Inventory, Work in Process, Gross
Work in process
Stockholders' Equity
Shareholders' Equity and Share-Based Payments [Text Block]
Common Stock Warrant Liability [Member]
Common Stock Warrant Liability [Member]
Common stock warrant liability [Member]
Common stock warrant liability [Member]
Shares granted to date
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total
General and Administrative Expense [Member]
General and Administrative [Member]
Operating Lease, Liability
Total
Operating Lease, Liability, Total
Auditor Firm ID
Auditor Firm ID
Debt instrument interest period
Debt Instrument Interest Period
Debt instrument interest period.
Stockholders' Equity, Reverse Stock Split
Reverse stock split
Forecast [Member]
Scenario Forecast [Member]
Proceeds from sale of common stock and pre-funded warrants
Proceeds From Sale Of Common Stock And Pre Funded Warrants
Proceeds from sale of common stock and pre-funded warrants.
Essentialis, Inc.
Essentialis Inc [Member]
Essentialis, Inc. [Member]
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Change in valuation allowance
Text Block [Abstract]
Debt Instrument, Maturity Date Range, Start
Debt instrument maturity start date
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Weighted average shares - basic
Weighted-average common shares outstanding - basic
Scenario [Axis]
Contingent upon FDA Approval of DCCR for Treatment of PWS Tranche One [Member]
Contingent upon FDA approval of DCCR for treatment of PWS tranche one.
Deferred tax assets lease liability.
Deferred Tax Assets Lease Liability
Lease liability
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Income Tax Provision (Benefit) Computed by Applying Statutory Income Tax Rate to Pretax Income (Loss)
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset
Prepaid Expenses And Other Current Assets Policy [Text Block]
Prepaid Expenses And Other Current Assets Policy [Text Block]
Prepaid Expenses and Other Current Assets
Subsequent Events
Subsequent Events [Text Block]
Long-Term Debt
Long-Term Debt, Total
Amount borrowed
Jefferies LLC [Member]
Jefferies LLC [Member]
Jefferies LLC.
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted, Total
Less: Earnings attributable to participating securities, diluted
Less: Undistributed earnings attributable to participating securities, diluted
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Change in valuation allowance
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche B [Member]
Cost of Goods and Service [Policy Text Block]
Cost of Goods Sold
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Leasehold Improvements [Member]
Leasehold Improvements [Member]
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value Disclosures [Text Block]
Fair Value of Financial Instruments
FDA Approval OF VYKATXR Tranche one [Member]
FDA Approval OF VYKATXR Tranche one [Member]
Fda approval of vykatxr tranche one.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Debt Instrument, Name [Domain]
Debt Instrument, Name
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Summary of Gross Unrecognized Tax Benefits
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Plan Name [Domain]
Plan Name
Debt Instrument, Fee Percentage
Debt instrument, fee percentage.
Debt instrument fee
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Credit Facility [Axis]
Share based compensation arrangement by share based payment award options exercised intrinsic value.
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
Stock options exercised, intrinsic value
Deferred tax assets, capitalized research and development.
Deferred Tax Assets, Capitalized Research And Development
Capitalized research and development
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Options exercisable at end of period (in dollars per share)
Business Description and Basis of Presentation [Text Block]
Overview
Number of Common Shares
Number of Common Warrant Shares
Class of Warrant or Right, Outstanding
Balance at the end of period, in shares
Balance at the beginning of period, in shares
Operating lease liabilities
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Effective Income Tax Reconciliation Orphan Drug Credit
Effective income tax reconciliation orphan drug credit.
Orphan Drug Credit
Orphan Drug Credit
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Other
Class of Warrant or Right [Table]
Class Of Warrant Or Right [Table]
Foreign Tax Jurisdiction [Member]
Foreign Tax Authority [Member]
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment, Net
Area of Real Estate Property
Area of operating lease
Entity Address, City or Town
Entity Address, City or Town
Final Principal Fee Payment Percentage
Final principal fee payment percentage.
Final principal fee payment percentage
Stock repurchased during period, shares
Stock Repurchased During Period, Shares
Repurchase of common stock
Warrants and rights immediately exercisable term.
Warrants And Rights Immediately Exercisable Term
Warrants and rights immediately exercisable term
Asset Acquisition, Contingent Consideration, Liability, Noncurrent
Contingent liability for Essentialis purchase price
Essentialis purchase price contingency liability
Number of Reportable Segments
Number of reportable segments
Security Exchange Name
Security Exchange Name
Credit Facility [Domain]
Principal amount of term loans
Long-Term Debt, Gross
Long-term debt
Other
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Property, Plant and Equipment, Gross
Property and equipment, gross
Property, Plant and Equipment, Gross, Total
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Ending Balance
Underwritten public offering.
Underwritten Public Offering [Member]
Underwritten Public Offering [Member]
Deferred tax liabilities right-of-use assets.
Deferred Tax Liabilities Right Of Use Assets
Right-of-use assets
Counterparty Name [Axis]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss before income taxes
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Options vested and expected to vest at end of period (shares)
Expiration period
Expiration Date
Class of warrant or right warrants expiration month and year.
Class Of Warrant Or Right Warrants Expiration Month And Year
Measurement Input Type [Domain]
Measurement Input Type
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name
Foreign jurisdictions
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent
Inventory, Net
Total inventory, net
Inventory, net
Sales Agreement [Member]
Sales agreement.
Sales Agreement [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Statistical Measurement [Domain]
Statistical Measurement
Asset Purchase
Asset purchase.
Asset Purchase [Domain]
Weighted Average Exercise Price per Share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Exercise price of warrants (in dollars per share)
Share-Based Payment Arrangement, Expense
Stock-based compensation expense
Stock-based compensation expense
Document Period End Date
Document Period End Date
Long Term Debt Outstanding
Long term debt outstanding.
Long-term debt outstanding
Title and Position [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Defined Contribution Plan, Cost
Matching contribution by Company
ICFR Auditor Attestation Flag
Long-Term Debt [Text Block]
Long-term Debt
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Common stock, maximum aggregate purchase price
Common Stock Maximum Aggregate Purchase Price
Common stock, maximum aggregate value purchase price.
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units [Member]
Outstanding Restricted Stock Units [Member]
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Vesting [Axis]
Income Tax Reconciliation Net Operating Loss Expiration
Income tax reconciliation net operating loss expiration.
Net operating loss expiration
Net operating loss expiration
Warrants exercised
Exercise of common stock warrants (shares)
Class of warrant or right exercised.
Class Of Warrant Or Right Exercised
Segment Reporting Cash Operating Expenses
Segment reporting cash operating expenses.
Cash operating expenses
Cash operating expenses
IRELAND
Ireland
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Change in tax laws or rates
Change Charged to Other Comprehensive Income
Change charged to other comprehensive income.
Foreign income taxes paid
Income Tax Paid, Foreign, before Refund Received
Lessee, operating lease month and year of expiration.
Lessee Operating Lease Month And Year Of Expiration
Operating lease, expiration
Capital Units, Authorized
Capital stock, shares authorized
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
Foreign jurisdictions
Reserves and accruals
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Total
Lessee, Operating Lease, Liability, to be Paid, Year Two
2027
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Balance as of December 31, 2025
Balance as of December 31, 2024
Finite-Lived Intangible Assets, Gross
Amount
Finite-Lived Intangible Assets, Gross, Total
Cash and Cash Equivalent [Table]
Schedule Of Cash And Cash Equivalents [Table]
Number of tranches
Number Of Tranches
Number Of Tranches
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Weighted average shares - diluted
Weighted-average common shares outstanding - diluted
Purchase price contingent liability.
Purchase Price Contingent Liability [Member]
Purchase price contingent liability [Member]
Entity File Number
Entity File Number
Securities Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Securities Purchase Agreement [Member]
Accounting Standards Update 2023-07 [Member]
ASU No. 2023-07 [Member]
Cover
Cover [Abstract]
Measurement Input Type [Axis]
Measurement Input Type
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Restricted stock units cancelled/forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum
Percentage of outstanding stock maximum
Supplemental Balance Sheet Disclosures [Text Block]
Balance Sheet Components
Summary of Change in the Valuation Allowance
Summary of Valuation Allowance [Table Text Block]
Scenario [Domain]
US Treasury Securities [Member]
US Treasury Securities [Member]
Number of Operating Segments
Number of operating segments
Sale of Stock [Domain]
Sale of Stock
Segment Reporting Disclosure [Text Block]
Segment Reporting
Schedule Of Significant Accounting Policies [Table]
Schedule Of Significant Accounting Policies [Table]
Schedule Of Significant Accounting Policies [Table]
Noncash Lease Expense
Non-cash lease expense.
Non-cash lease expense
Non-cash lease expense
Revenue from Contract with Customer, Including Assessed Tax
Product revenue, net
March 2022 Warrants [Member]
March Two Thousand Twenty Two Warrants [Member]
March two thousand twenty two warrants.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Options canceled/forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Subsequent Event [Table]
Income tax reconciliation change in fair value of contingent consideration.
Income Tax Reconciliation Change In Fair Value Of Contingent Consideration
Change in fair value of contingent consideration
Contingent consideration remeasurement
Cantor [Member]
Cantor Fitzgerald And Co [Member]
Cantor Fitzgerald and Co.
Finite-Lived Intangible Assets, Net
Net Amount
Finite-Lived Intangible Assets, Net, Beginning Balance
Finite-Lived Intangible Assets, Net, Ending Balance
Change in tax laws or rates
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
2018 PIPE Warrants [Policy Text Block]
2018 PIPE Warrants [Policy Text Block]
2018 PIPE Warrants
Debt instrument date of final borrowings
Debt Instrument Date of Final Borrowings
Debt Instrument Date of Final Borrowings
Lessee, operating lease commencement month and year.
Lessee Operating Lease Commencement Month And Year
Operating lease beginning date
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Options vested and expected to vest at end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Contractual Term
Property, Plant and Equipment, Useful Life
Estimated useful lives of property and equipment
Recent Adopted Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Operating Lease Liability Maturity
Reconciliation of Undiscounted Future Minimum Lease Payments Remaining under Operating Lease
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Other nontaxable or nondeductible items
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Tranche Two [Member]
Tranche two.
Income (Loss) from Continuing Operations before Income Taxes, Domestic
United States
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Depreciation
Depreciation expense
Depreciation, Total
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Unrecognized stock based compensation expense
Operating lease, term of contract
Lessee, Operating Lease, Term of Contract
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Number of shares available for issuance under the plan on the first day of each year
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Operating Lease, Liability, Current
Operating lease liabilities
Operating lease, short-term liability
Document Transition Report
Document Transition Report
Deferred Tax Assets, Net
Net deferred tax assets
Operating Expenses
Total operating expenses
Cash operating expenses
Total operating expenses
Change in fair value of contingent consideration policy.
Change In Fair Value Of Contingent Consideration Policy [Text Block]
Change in Fair Value of Contingent Consideration
Payments to repurchase common stock
Payments for Repurchase of Common Stock
Payment for repurchase of common stock
Effective Income Tax Rate Reconciliation, Net Operating Loss Expiration, Percent
Effective income tax rate reconciliation, net operating loss expiration, percent.
Net operating loss expiration
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant date fair value
Product Revenue Reserve for Rebates, Returns, and Other Incentives Current
Product revenue reserve for rebates, returns, and other incentives current.
Product revenue reserve for rebates, returns, and other incentives
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary of Stock Option and Restricted Stock Unit Transactions
Assets, Fair Value Disclosure [Abstract]
Assets
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent
Stock-based compensation
Section 162(m) limitation
Income Tax Reconciliation Section One Sixty Two limitation
Income tax reconciliation section one sixty two limitation.
Section 162(m) limitation
Finite-Lived Intangible Assets [Line Items]
Finite Lived Intangible Assets [Line Items]
Earnings Per Share [Text Block]
Net Income (Loss) per Share
Unrecognized tax benefits that would impact effective tax rate
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Measurement Input, Expected Dividend Rate [Member]
Expected Dividend Yield [Member]
May 2023 Tranche B Pre-funded Warrants [Member]
May Two Thousand Twenty Three Tranche B Pre Funded Warrants [Member]
May 2023 Tranche B Pre-funded warrants.
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Summary of Restricted Stock Unit Transactions
Computer Equipment [Member]
Computer Hardware [Member]
Net loss
Net loss
Net operating loss
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Options outstanding at end of period
Operating Lease, Cost
Operating lease cost
Income Tax Contingency [Line Items]
Income Tax Contingency [Line Items]
Warrants and Rights Outstanding, Term
Measurement term
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Dividend rate
Expected dividend yield
Operating Lease, Payments
Operating cash flows from operating leases
Income Tax Authority, Name [Axis]
Income Tax Authority, Name
Common Stock Warrant [Member]
Common Stock Warrants [Member]
Common stock warrants.
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate
Oxford Financing LLC And Its Affiliates [Member]
Oxford Financing LLC And Its Affiliates [Member]
Oxford [Member]
Document Fiscal Year Focus
Document Fiscal Year Focus
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to clinical trial services received from vendors, such as accrued contract research organization costs, patient costs, clinical site costs and clinical product cost. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Clinical Trial Costs Current
Accrued clinical trial site costs
Shares issued from sale of common stock
Shares Issued From Sale Of Common Stock
Shares issued from sale of common stock.
Retirement Benefits [Abstract]
Interest Paid, Including Capitalized Interest, Operating and Investing Activities
Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total
Interest paid
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
Schedule of Income (Loss) before Provision for Income Taxes
Research and Development Expense [Member]
Research and Development [Member]
Research Tax Credit Carryforward [Member]
Research Tax Credit Carryforward [Member]
Employees [Member]
Employees.
Tranche 1 [Member]
Tranche One [Member]
Tranche one.
Finite-Lived Intangible Asset, Expected Amortization, Year One
2026
Components of Deferred Tax Assets [Abstract]
Unrecognized Tax Benefits [Roll Forward]
Class of warrants exercised.
Class Of Warrants Exercised
Warrants exercised
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Public Offering
Public Offering [Member]
Public Offering [Member]
Lessee, Operating Lease, Liability, to be Paid, Year One
2026
Net income (loss) attributable to common stockholders - basic
Net Income (Loss) Available to Common Stockholders, Basic
Net income (loss) attributable to common stockholders - basic
Effective Income Tax Rate Reconciliation [Line Items]
Debt Instrument [Axis]
Debt Instrument
Share-Based Payment Arrangement [Abstract]
Total assets
Assets, Fair Value Disclosure
Deferred Tax Liabilities, Intangible Assets
Intangible assets
Sale of Stock [Axis]
Sale of Stock
Derivatives, Policy [Policy Text Block]
Common Stock Purchase Warrants and Other Derivative Financial Instruments
Less: Undistributed earnings attributable to participating securities, basic
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic
Undistributed Earnings (Loss) Allocated to Participating Securities, Basic, Total
Less: Earnings attributable to participating securities, basic
Title of 12(b) Security
Title of 12(b) Security
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Stock-based compensation
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Options canceled/forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Restricted stock units cancelled/forfeited (in dollars per share)
Money Market Funds [Member]
Money Market Funds [Member]
Operating Lease Annually Increase Percentage
Operating lease annually increase percentage.
Rent payments annual increase percentage
Income Tax Disclosure [Text Block]
Income Taxes
Schedule Of Long Term Debt Interest Expenses [Table Text Block]
Schedule of long term debt interest expenses.
Schedule of Interest Expense Related to the Long-term Debt
Debt Securities, Available-for-Sale, Allowance for Credit Loss
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Ending Balance
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Beginning Balance
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Total
Allowance for credit losses related to available-for-sale debt securities
Class of Warrant or Right [Line Items]
Class Of Warrant Or Right [Line Items]
Debt Instrument, Maturity Date Range, End
Debt instrument maturity end date
Percentage of Increase in Applicable Rate of Interest under Termination of the Lenders' Commitments
Percentage of increase in applicable rate of interest under termination of the lenders' commitments.
Percentage of increase in applicable rate of interest under termination of the lenders' commitments
Property, Plant and Equipment [Table Text Block]
Schedule of Property and Equipment
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Ending balance (in dollars per share)
Beginning balance (in dollars per share)
Asset acquisition contingent consideration arrangements earn out payment,
Asset Acquisition Contingent Consideration Arrangements Earn Out Payment
Maximum potential cash earnout payments
Income Tax Disclosure [Abstract]
Shares issued from sale of pre-funded warrants
Shares Issued From Sale Of Pre-Funded Warrants
Shares issued from sale of pre-funded warrants.
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Beginning balance
Unrecognized Tax Benefits
Ending balance
United Kingdom
UNITED KINGDOM
Measurement Frequency [Domain]
Measurement Frequency
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Statement of Income Location, Balance [Axis]
Income Statement Location
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Trading Symbol
Trading Symbol
Intangible Asset, Finite-Lived [Table]
Schedule Of Finite Lived Intangible Assets [Table]
Director [Member]
Subsequent Event Type [Axis]
Contingent upon Certain Commercial Milestones [Member]
Contingent upon certain commercial milestones.
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Expected life (years)
Fair Value, Recurring [Member]
Fair Value, Measurements, Recurring [Member]
Lessee, Operating Lease, Liability, to be Paid
Total lease payments
ASU No. 2016-13 [Member]
Accounting Standards Update 2016-13 [Member]
Performance-Based Restricted Stock Units [Member]
Performance-based restricted stock units.
Performance-Based Restricted Stock Units [Member]
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less interest
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Federal research and development credits
Federal research and development credits
Equity Components [Axis]
Equity Components
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Options exercisable at end of period
Weighted average remaining vesting period
Schedule of supplemental cash flow information related to leases.
Schedule Of Supplemental Cash Flow Information Related To Leases Table [Text Block]
Schedule Of Supplemental Cash Flow Information Related To Leases
Repurchase an Aggregate Amount
Stock Repurchase Program Increase In Authorized Amount
Stock repurchase program increase in authorized amount.
Public offering price per pre-funded warrant.
Public Offering Price Per Pre Funded Warrant
Public offering price per pre-funded warrant
March 2022 Pre-funded Warrants [Member]
March Two Thousand Twenty Two Pre Funded Warrants [Member]
March two thousand twenty two pre funded warrants.
Total other income (expense), net
Nonoperating Income (Expense)
Less total other income, net
Corporate Debt Securities And Commercial Paper [Member]
Corporate Debt Securities And Commercial Paper [Member]
Corporate Debt Securities and Commercial Paper [Member]
Equity Component [Domain]
Equity Component
October 2023 Pre-funded Warrants [Member]
October Two Thousand Twenty Three Pre-funded Warrants [Member]
Oct 2023 Pre-funded warrants.
Asset Class [Axis]
Sale and issuance of warrants to purchase common stock
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
James Mackaness [Member]
James Mackaness.
James Mackaness
Other
State and Local Tax Jurisdiction, Other [Member]
Contingent receipt upon exerise of warrants and future performance of company
Contingent Receipt Upon Exerise Of Warrants And Future Performance Of Company
Contingent receipt upon exerise of warrants and future performance oF company.
Document Annual Report
Document Annual Report
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Number of shares purchases by employees
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Contractual term of option
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation and amortization
Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
Effective Income Tax Rate Reconciliation, Tax Contingency, Amount, Total
Worldwide changes in UTB
Maximum [Member]
Maximum [Member]
Copay Assistance and Returns [Member]
Copay assistance and returns.
Liabilities, Fair Value Disclosure
Total liabilities
Statistical Measurement [Axis]
Statistical Measurement
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Options exercised (in dollars per share)
Finite-Lived Intangible Assets, Accumulated Amortization
Accumulated Amortization
Net Income (Loss) Available to Common Stockholders, Diluted
Net income (loss) attributable to common stockholders - diluted
Net income (loss) attributable to common stockholders - diluted
Finance Lease, Principal Payments
Financing cash flows from finance leases
Principal paid on finance lease liabilities
Concentration Risk, Credit Risk, Number of Banks
Concentration Risk Credit Risk Numberof Banks
Number of commercial banks
Milestones payment.
Milestones payment
Milestones Payment
Cash and Cash Equivalents [Abstract]
Income Tax Contingency [Table]
Income Tax Contingency [Table]
Debt instrument date of final required payment
Debt Instrument Date Of Final Required Payment1
Debt instrument date of final required payment1.
Deferred Tax Assets, Operating Loss Carryforwards
Federal and state net operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards, Total
Tax Credit Carryforward [Axis]
Tax Credit Carryforward
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Long-Lived Assets
Two Thousand and Ten and Two Thousand and Twelve Convertible Promissory Notes [Member]
Two Thousand And Ten And Two Thousand And Twelve Convertible Promissory Notes [Member]
2010 and 2012 Convertible Promissory Notes [Member]
Cash and Cash Equivalents [Line Items]
Cash And Cash Equivalents [Line Items]
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent
State income taxes, net of federal effect
March Two Thousand Twenty Two Underwritten Public Offering [Member]
March 2022 Underwritten Public Offering.
March 2022 Underwritten Public Offering [Member]
Employees and directors.
Employees and Directors [Member]
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Schedule of Future Amortization Expense
Time Deposits, at or Above FDIC Insurance Limit
FDIC insurance limit
Entity Public Float
Entity Public Float
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Volatility
Preferred Stock, Shares Authorized
Convertible preferred stock, shares authorized
Preferred stock, shares authorized
Accrued interest payable
Interest Payable, Current
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class
Loan And Security Agreement [Member]
Loan And Security Agreement [Member]
Loan and Security Agreement [Member]
Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Percent
Effective Income Tax Rate Reconciliation, Cross-Border Tax Effect, Percent, Total
Cross-border tax laws
Derivative Financial Instruments, Liabilities [Member]
Derivative Financial Instruments, Liabilities
Employee Stock [Member]
Employee Stock Purchase Plan [Member]
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Not Previously Recorded
Credit losses related to available-for-sale debt securities
Entity Registrant Name
Entity Registrant Name
Exercisable warrants maximum aggregate exercise price.
ExercisableWarrants Maximum Aggregate Exercise price
Exercisable warrants maximum aggregate exercise price
Warrants To Purchase Stock [Member]
Warrants To Purchase Common Stock [Member]
Warrants to Purchase Stock [Member]
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Unrealized Losses
Unrealized Losses
Entity Voluntary Filers
Entity Voluntary Filers
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Finite-Lived Intangible Asset, Expected Amortization, Year Two
2027
Schedule Of Significant Accounting Policies [Line Items]
Schedule Of Significant Accounting Policies [Line Items]
Schedule Of Significant Accounting Policies [Line Items]
Subsequent Events [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year Three
2028
Provision (benefit) for income taxes
Provision for income taxes
Income Tax Expense (Benefit)
Measurement Frequency [Axis]
Measurement Frequency
Amendment Description
Proceeds from Issuance of Common Stock
Net proceeds from sale of common stock
Proceeds from the sale of common stock, net of issuance costs
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Fair Value of Convertible Preferred Stock Warrant Liability
Effective Income Tax Rate Reconciliation, Section 382 Limitation, Percent
Effective income tax rate reconciliation, section 382 limitation, percent.
Section 382 limitation
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Liability Class [Axis]
Liability Class
Contingent upon FDA Approval of DCCR for Treatment of PWS [Member]
Contingent upon FDA approval of DCCR for treatment of PWS.
Commitments and contingencies.
Commitments And Contingencies [Line Items]
Commitments And Contingencies [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Stock units granted
Restricted stock units granted
Deferred Tax Assets, Tax Credit Carryforwards, Other
Other deferred tax assets
Inventory, Policy [Policy Text Block]
Inventory
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Income Tax Paid, State and Local, after Refund Received
Total U.S. State and Local
Total U.S. State and Local
Percentage of the probability of achieving the milestone.
Percentage Of Probability Of Achieving Milestone
Percentage of probability of achieving milestone
Rebates [Member]
Rebates.
Underwriter [Member]
Underwriter [Member]
Underwriter [Member]
Warrants Issued to Underwriter to Purchase Common Stock [Member]
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Decrease related to prior year tax positions
Discounts and Chargebacks [Member]
Discounts and chargebacks.
Share-Based Payment Arrangement [Policy Text Block]
Stock-Based Compensation
Selling, General and Administrative Expenses [Member]
Selling, General and Administrative Expenses [Member]
Sale of Stock, Number of Shares Issued in Transaction
Additional shares of common stock delivered
May 2023 Tranche A Pre-funded Warrants [Member]
May Two Thousand Twenty Three Tranche A Pre Funded Warrants [Member]
May two thousand twenty three tranche a pre funded warrants.
Number of Installments
Number of Installments
Number of installments
Stock Issued During Period, Shares, New Issues
Issuance of common stock (shares)
Sale of common stock, net of issuance costs (shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Restricted stock units vested
Restricted stock units vested
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162(M) Limitation, Percent
Effective income tax rate reconciliation, nondeductible expense, section 162(m) limitation, percent.
Section 162(m) limitation
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net income (loss) per share - diluted
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Schedule of Cash Operating Expenses Reconciled to Net Income (Loss) on Consolidated Basis
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Title and Position [Domain]
Non Rule 10b51 Arr Modified Flag
Non Rule 10b51 Arr Modified Flag.
City Area Code
City Area Code
Payments for Rent
Rent payments
Auditor Name
Auditor Name
Two thousand and fourteen equity incentive plan and two thousand twenty inducement equity incentive plan.
Two Thousand And Fourteen Equity Incentive Plan And Two Thousand Twenty Inducement Equity Incentive Plan [Member]
2014 Plan and Inducement Plan [Member]
Debt Instrument, Face Amount
Debt instrument, face amount
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Intangible Assets
Schedule of Intangible Assets and Goodwill [Table Text Block]
Schedule of Intangible Assets
Liquidity
Liquidity Disclosure [Text Block ]
Liquidity disclosure.
Warrants and rights exercisable term from following receipt of U.S. Food and drug administration approval.
Warrants And Rights Exercisable Term From Following Receipt of U.S. Food and Drug Administration Approval
Warrants and rights exercisable term from following receipt of U.S. Food and drug administration approval
Deferred Tax Assets, Tax Credit Carryforwards
Research and other credits
Deferred Tax Assets, Tax Credit Carryforwards, Total
Counterparty Name [Domain]
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Change in research and development credits
Federal research and development credits
Federal research and development credits
Tranche Three [Member]
Tranche three.
Variable Lease, Cost
Variable lease cost
Operating Lease, Weighted Average Remaining Lease Term
Operating lease remaining term
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split ratio
Lease Expiration Date
Operating lease, expiration date
March Thousand Twenty Two Public Offering Of Common Stock [Member]
March thousand twenty two public offering of common stock.
Reverse stock split.
Reverse Stock Split Policy [Policy Text Block]
Reverse Stock Split
Lease, Cost
Total operating lease cost
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Property, Plant and Equipment, Net
Property and equipment, net
Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Options exercisable at end of period (shares)
Operating Income (Loss)
Operating income (loss)
Operating income (loss)
Class Of Warrant Or Right, Warrant Term
Class Of Warrant Or Right Warrant Term
Warrants term
November Two Thousand And Twenty Five Equity Accelerated Share Repurchase Agreement [Member]
November two thousand and twenty five equity accelerated share repurchase agreement member.
November 2025 Accelerated Share Repurchase Agreement
Two thousand eighteen PIPE warrant liability to purchase common stock.
Two Thousand Eighteen P I P E Warrant Liability To Purchase Common Stock [Member]
2018 PIPE Warrant Liability [Member]
Share-Based Payment Arrangement, Noncash Expense
Stock-based compensation expense
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Stock-based compensation
Measurement Input, Price Volatility [Member]
Volatility [Member]
Operating lease, weighted average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Operating Lease, Liability, Noncurrent
Long-term lease liabilities
Long-term operating lease liabilities
Fair Value, Inputs, Level 1 [Member]
Level 1 [Member]
Class of Stock [Line Items]
Lease, Cost [Table Text Block]
Schedule of Components of Lease Expense
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Mutual Consent of Soleno and Oxford [Member]
Mutual consent of Soleno and Oxford.
Auditor Location
Auditor Location
Incentive Stock Options [Member]
Incentive Stock Options [Member]
ISOs [Member]
Summary of Outstanding Common Stock Warrants
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Long-term Accrued Interest Payable
Long-term accrued interest payable.
Long-term accrued interest payable
Deferred tax assets capitalized research and development expenses amortization period.
Deferred Tax Assets Capitalized Research And Development Expenses Amortization Period
Research and development costs, amortization period
US Government Corporations and Agencies Securities [Member]
Other Government Agency Securities [Member]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Net Income (Loss) per Share
Income Tax Jurisdiction [Domain]
Income Tax Authority
Entity Interactive Data Current
Entity Interactive Data Current
March 2022 Common Warrants [Member]
March Two Thousand Twenty Two Common Warrants [Member]
March two thousand twenty two common warrants.
Statement of Income Location, Balance [Domain]
Income Statement Location
Furniture and Fixtures [Member]
Furniture and Fixtures [Member]
Debt Instrument, Periodic Payment, Interest
Debt instrument final interest payment
His Majesty's Revenue and Customs (HMRC) [Member]
Her Majesty's Revenue and Customs (HMRC) [Member]
Warrant Liability Disclosure [Text Block]
Warrants
Warrant Liability Disclosure [Text Block]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Change in value of liabilities
Components of Deferred Tax Liabilities [Abstract]
Deferred tax liabilities:
Share-Based Payment Arrangement, Expense, Tax Benefit
Income tax benefits recognized from stock-based compensation
Entity Tax Identification Number
Entity Tax Identification Number
Debt Instrument, Term
Debt instrument term
Debt instrument maturity date
Income Tax Authority, Name [Domain]
Income Tax Authority, Name
Proceeds from issuance or sale of equity
Proceeds from issuance or sale of equity
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Local Phone Number
Local Phone Number
May Two Thousand Twenty Three Tranche B Pre Funded Exchange Warrants Member
May two thousand twenty three tranche B pre funded exchange warrants.
May 2023 Tranche B Pre-funded Warrants [Member]
Amortization Of Debt Issuance Costs And Accretion Of Final Interest Payment
Amortization of debt issuance costs and accretion of final interest payment.
Amortization of debt issuance costs and accretion of final interest payment
Other Liabilities, Current
Other current liabilities
Total other current liabilities
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Future stock-based compensation for unvested employee options granted and outstanding
Short-Term Lease, Cost
Short-term lease cost
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Denominator:
Auditor Opinion
Auditor Opinion [Text Block]
May Two Thousand Twenty Three Tranche A Pre Funded Exchange Warrants Member
May two thousand twenty three tranche A pre-funded exchange warrants.
May 2023 Tranche A Pre-funded Warrants [Member]
Accounting Policies [Abstract]
Asset acquisition contingent consideration change in fair value.
Asset Acquisition Contingent Consideration Change In Fair Value
Change in fair value of contingent consideration
Change in fair value of contingent consideration
Other Sundry Liabilities, Current
Other
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year Four
2029
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Number of shares available for grant
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Future stock-based compensation, requisite service period
Accrued consulting and professional fees
Accrued Professional Fees, Current
Stock, Class of Stock [Table]
Entity Emerging Growth Company
Entity Emerging Growth Company
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Options vested and expected to vest at end of period
Tax Credit Carryforward, Name [Domain]
Tax Credit Carryforward, Name